Replies to post #324330 on Avid Bioservices Inc (CDMO)

[BioBS2012]

JUST ASK THE QUESTION:

WHO WANTS TO PAY 8MIL$ for SOMETHING THAT BP DOESN'T WANT TO PAY 8MIL$ FOR?

8 Milion $ is for BP the cost of a big medical event with Doctors and Credit Card shopping for Doctors wifes, wining & dining and entertainment in exotic luxury resorts and hotels, plane tickets, boat trips and Rolex Hand-outs as if it where chocolates.

Yet BP that sometimes pays a few hundred million for Stage I companies doesn't want to pay 10Milion$ to secure the PPHM IP and to be sure they don't find it at the other end of the war if they do something in the PtdSer arena? Who believes that. .
.
.

An alternative way of looking at this would be, WHY would a BP pay even a dime for a drug that has consistently failed to live up to the hype of its management. In the end, BP didn't pay a dime for this platform, so there is that truth to deal with. Even $AZN ran away after the failure of SUNRISE - no surprise. No company worth its salt would want to pay a penny for a failed molecule (should be a crime to call it a drug), and this one failed REPEATEDLY.

Ok, I will go eat my "salted peanuts" and breadcrumbs now.

Go $CDMO.

.......said Roger J. Lias, Ph.D., president and chief executive officer of Avid. "Importantly, this deal marks the completion of our transition to a dedicated CDMO, while providing additional capital, both upfront and potentially downstream, to support our CDMO business."